We describe a new method for measuring the in vitro rate of hydrolysis of the muscle relaxant succinylcholine.
Ten samples can be assayed in duplicatein an hour. This method is suited to routineuse in any laboratorythathas a simple spectrophotometer.
The mean activity in 11 individuals with the cholinesterase phenotype UU was 105 U/L, for seven UA heterozygotes 61 U/L, and for three AA homozygotes 4 U/L. To the extent allowed by extrapolation from in vitro to in vivo results, this method should increase diagnostic accuracy and may directly predict duration of succinylcholine-induced apnea.
Additional Keyphrases: reference interval genetic variants
We describe here a simple assay for plasma cholinesterase (acylcholine acyl-hydrolase, EC 3.1.1.8), which involves measurement of the in vitro rate of hydrolysis of succinylcholine. We believe that this assay is directly applicable to the detection of individuals who are abnormally sensitive to the muscle relaxant, succinylcholine chloride (Scoline, Suxamethonium), a drug used during anesthesia to induce a paralysis usually lasting 1-2 mm. The short duration of action is ascribable to rapid hydrolysis of the drug by plasma cholinesterase.
In some individuals, however, it produces a prolonged paralysis, with apnea lasting up to 24 h. This may be a result of genetic variations of the enzyme or pathologically decreased activity (1) . As discussed in recent comprehensive reviews (1, 2) The assay has the required sensitivity, autohydrolysis is monitored by a blank containing a specific cholinesterase inhibitor, and only 0.1 mL of plasma and a routine quality spectrophotometer are required.
The simplicity of this method should place it within the capability of most laboratories. 
Materials and Methods

Materials
Results
Regarding the choline oxidase and peroxidase reaction system, we verified the previous claim (21) that absorbance at 500 nm and choline concentration are linearly related. After development, the color was stable for at least 20 mm at 37 #{176}C. A typical reading for 0. 
Discussion
We developed this method in an attempt to improve the prediction of succinylcholine sensitivity by direct measurement of the in vitro rate of succinyicholine hydrolysis. We have attempted to mimic the in vivo situation. Our choice of phosphate buffer of physiological pH and ionic strength allows comparison with previous work (16) . The substrate concentration, 0.47 mmol/L, lies between the Km values of the U and A forms of the enzyme, and we selected it to maximize the difference in hydrolysis rates. The sample volume of plasma, 50 ML, is the smallest convenient volume that gives a reaction rate sufficient for adequate precision. We chose physostigmine, which specifically inhibits cholinesterases (23), as the inhibitor in the blank to ensure that any contribution from other esterases is included with the autohydrolysis in the blank reaction. The contribution of other esterases could otherwise be of major significance, especially when one is measuring homozygotes for the atypical enzyme. The choline oxidase/peroxidase reagent system was previously described for the measurement of choline produced by hydrolysis from benzoylcholine (21) . To calibrate, we used a pure choline standard-choline chloride in this work, but in retrospect the nonhygroscopic choline iodide would have been preferable (24) .
Evidence that the assay measures cholinesterase activity (26) . Finally, abolition of activity by anticholinesterase antiserum is evidence of the assay's specificity for cholinesterase.
Although the UU and AA phenotypes are clearly separated, there is an overlap between results from UU and UA individuals. Nevertheless, if one assumes that the in vitro hydrolysis rate reflects the in vivo rate, it should be possible to predict which heterozygotes are at risk. A clinical assessment of the method is required and may allow estimation of the duration of apnea. In the meantime, values of <50 UIL could be tentatively regarded as suggesting succinylcholine sensitivity, because they are about one-half of the normal values for the UU phenotype. Previous in vitro rate estimates are 70,90, and 100 U/L, as compared with the slower in vivo rate of 20 U/L (27) . The in vivo situation is complicated by the rapid transfer of most of the drug from plasma to the interstitial space (28) , so that the pharmacokinetic behavior of succinylcholine is not entirely explained by hydrolysis in plasma. Moreover, knowledge of these mechanisms is insufficient to allow dogmatic extrapolation from in vitro assays. Under our reaction conditions it is not practicable to distinguish the phenotypes by dibucaine inhibition. Although we have shown differences between the UU, UA, and AA phenotypes, there is overlap, and autohydrolysis of succinylcholine makes difficult the precise measurement of dibucaine inhibition of the AA phenotype. This finding is in contrast to previous work that claimed that dibucaine resistance, under conditions similar to ours, identified the AA phenotype (18) . Theoretically, dibucaine resistance could be demonstrated if the succinylcholine concentration were to be increased, but this would reduce the difference in the noninhibited rates of hydrolysis for the U and A enzymes.
Phenotyping specimens, probably best done by existing methods (10, 22) , is complementary to the detection of sensitive individuals by our method.
Because this method directly measures succinylcholine hydrolysis by plasma, it should overcome the problems of extrapolating from studies with other substrates. There are several reports of anomalous cholinesterase activity within family trees (2, 14, 18, 29, 30) , and we have also seen this. Our method has the potential to determine the succinylcholine sensitivity of these individuals, and may allow a direct estimate of apnea time; we expect clinical trials to confirm this. The method is rapid and simple, and allows direct detection of succinylcholine sensitivity by any laboratory with a simple spectrophotometer.
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